Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression
Maintaining good content uniformity (CU) is a significant challenge for low-dose oral tablets in particular when using direct compression (DC). Using 6 model active pharmaceutical ingredients, we show that a platform DC tablet formulation suitable for developing low-dose API with excellent CU can be...
Gespeichert in:
Veröffentlicht in: | Journal of pharmaceutical sciences 2017-07, Vol.106 (7), p.1772-1777 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1777 |
---|---|
container_issue | 7 |
container_start_page | 1772 |
container_title | Journal of pharmaceutical sciences |
container_volume | 106 |
creator | Sun, Wei-Jhe Aburub, Aktham Sun, Changquan Calvin |
description | Maintaining good content uniformity (CU) is a significant challenge for low-dose oral tablets in particular when using direct compression (DC). Using 6 model active pharmaceutical ingredients, we show that a platform DC tablet formulation suitable for developing low-dose API with excellent CU can be developed. This platform formulation is enabled by particle engineering, where an API of interest is loaded in a suitable porous carrier to form a uniform API-carrier composite. Powder properties of such composite particles are dictated by the properties of the carrier, which are insensitive to chemical structure and loading level of the API. Powder flowability, tabletability, tablet friability, and tablet disintegration time are all excellent and only vary within a narrow range among the 6 model APIs. Nearly 100% drug can be released in water from tablets composed of the 6 model APIs. Thus, the approach described here holds the promise for broad application in developing low-dose tablet products using DC possessing excellent CU and other critical quality attributes. |
doi_str_mv | 10.1016/j.xphs.2017.03.005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1879666344</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354917301612</els_id><sourcerecordid>1879666344</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-982fae671d3dfa4737e560020f3e198252577e1ecb8b531cb2059ddc0cdc81f43</originalsourceid><addsrcrecordid>eNp9kE1P3DAQhq0KVBboH-ih8pFL0rEd50PqpVo-WmkRK7E9W44zoV4l8dZOoPDr6-xSjpxGM_PMK81DyGcGKQOWf92mf3e_Q8qBFSmIFEB-IAsmOSR5HB2RBQDniZBZdUJOQ9gCQA5SfiQnvBScVxksyMta-9GaDunV8GAHRG-HB9o6H3tdd3Oj6bXz_dTp0bqBrmON657eT3aMBO7hWz1MrTbjtD9fuafk0gWkmxkYA62f6aX1aEa6dP3OYwgx6pwct7oL-Om1npFf11eb5Y9kdXfzc_l9lZiM8zGpSt5qzAvWiKbVWSEKlHn8DFqBLC4ll0WBDE1d1lIwU3OQVdMYMI0pWZuJM3JxyN1592fCMKreBoNdpwd0U1CsLKo8z0U2o_yAGu9C8Niqnbe99s-KgZqdq62anavZuQKhovN49OU1f6p7bN5O_kuOwLcDgPHLR4teBWNxMNjsnajG2ffy_wEX6ZRf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1879666344</pqid></control><display><type>article</type><title>Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Sun, Wei-Jhe ; Aburub, Aktham ; Sun, Changquan Calvin</creator><creatorcontrib>Sun, Wei-Jhe ; Aburub, Aktham ; Sun, Changquan Calvin</creatorcontrib><description>Maintaining good content uniformity (CU) is a significant challenge for low-dose oral tablets in particular when using direct compression (DC). Using 6 model active pharmaceutical ingredients, we show that a platform DC tablet formulation suitable for developing low-dose API with excellent CU can be developed. This platform formulation is enabled by particle engineering, where an API of interest is loaded in a suitable porous carrier to form a uniform API-carrier composite. Powder properties of such composite particles are dictated by the properties of the carrier, which are insensitive to chemical structure and loading level of the API. Powder flowability, tabletability, tablet friability, and tablet disintegration time are all excellent and only vary within a narrow range among the 6 model APIs. Nearly 100% drug can be released in water from tablets composed of the 6 model APIs. Thus, the approach described here holds the promise for broad application in developing low-dose tablet products using DC possessing excellent CU and other critical quality attributes.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1016/j.xphs.2017.03.005</identifier><identifier>PMID: 28322940</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>content uniformity ; Drug Carriers - chemistry ; Drug Compounding - methods ; Excipients - chemistry ; formulation ; manufacturability ; Neusilin ; particle engineering ; Pharmaceutical Preparations - administration & dosage ; Pharmaceutical Preparations - chemistry ; Porosity ; Powders ; Solubility ; tableting ; Tablets - chemistry</subject><ispartof>Journal of pharmaceutical sciences, 2017-07, Vol.106 (7), p.1772-1777</ispartof><rights>2017 American Pharmacists Association</rights><rights>Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-982fae671d3dfa4737e560020f3e198252577e1ecb8b531cb2059ddc0cdc81f43</citedby><cites>FETCH-LOGICAL-c422t-982fae671d3dfa4737e560020f3e198252577e1ecb8b531cb2059ddc0cdc81f43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28322940$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sun, Wei-Jhe</creatorcontrib><creatorcontrib>Aburub, Aktham</creatorcontrib><creatorcontrib>Sun, Changquan Calvin</creatorcontrib><title>Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression</title><title>Journal of pharmaceutical sciences</title><addtitle>J Pharm Sci</addtitle><description>Maintaining good content uniformity (CU) is a significant challenge for low-dose oral tablets in particular when using direct compression (DC). Using 6 model active pharmaceutical ingredients, we show that a platform DC tablet formulation suitable for developing low-dose API with excellent CU can be developed. This platform formulation is enabled by particle engineering, where an API of interest is loaded in a suitable porous carrier to form a uniform API-carrier composite. Powder properties of such composite particles are dictated by the properties of the carrier, which are insensitive to chemical structure and loading level of the API. Powder flowability, tabletability, tablet friability, and tablet disintegration time are all excellent and only vary within a narrow range among the 6 model APIs. Nearly 100% drug can be released in water from tablets composed of the 6 model APIs. Thus, the approach described here holds the promise for broad application in developing low-dose tablet products using DC possessing excellent CU and other critical quality attributes.</description><subject>content uniformity</subject><subject>Drug Carriers - chemistry</subject><subject>Drug Compounding - methods</subject><subject>Excipients - chemistry</subject><subject>formulation</subject><subject>manufacturability</subject><subject>Neusilin</subject><subject>particle engineering</subject><subject>Pharmaceutical Preparations - administration & dosage</subject><subject>Pharmaceutical Preparations - chemistry</subject><subject>Porosity</subject><subject>Powders</subject><subject>Solubility</subject><subject>tableting</subject><subject>Tablets - chemistry</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1P3DAQhq0KVBboH-ih8pFL0rEd50PqpVo-WmkRK7E9W44zoV4l8dZOoPDr6-xSjpxGM_PMK81DyGcGKQOWf92mf3e_Q8qBFSmIFEB-IAsmOSR5HB2RBQDniZBZdUJOQ9gCQA5SfiQnvBScVxksyMta-9GaDunV8GAHRG-HB9o6H3tdd3Oj6bXz_dTp0bqBrmON657eT3aMBO7hWz1MrTbjtD9fuafk0gWkmxkYA62f6aX1aEa6dP3OYwgx6pwct7oL-Om1npFf11eb5Y9kdXfzc_l9lZiM8zGpSt5qzAvWiKbVWSEKlHn8DFqBLC4ll0WBDE1d1lIwU3OQVdMYMI0pWZuJM3JxyN1592fCMKreBoNdpwd0U1CsLKo8z0U2o_yAGu9C8Niqnbe99s-KgZqdq62anavZuQKhovN49OU1f6p7bN5O_kuOwLcDgPHLR4teBWNxMNjsnajG2ffy_wEX6ZRf</recordid><startdate>201707</startdate><enddate>201707</enddate><creator>Sun, Wei-Jhe</creator><creator>Aburub, Aktham</creator><creator>Sun, Changquan Calvin</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201707</creationdate><title>Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression</title><author>Sun, Wei-Jhe ; Aburub, Aktham ; Sun, Changquan Calvin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-982fae671d3dfa4737e560020f3e198252577e1ecb8b531cb2059ddc0cdc81f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>content uniformity</topic><topic>Drug Carriers - chemistry</topic><topic>Drug Compounding - methods</topic><topic>Excipients - chemistry</topic><topic>formulation</topic><topic>manufacturability</topic><topic>Neusilin</topic><topic>particle engineering</topic><topic>Pharmaceutical Preparations - administration & dosage</topic><topic>Pharmaceutical Preparations - chemistry</topic><topic>Porosity</topic><topic>Powders</topic><topic>Solubility</topic><topic>tableting</topic><topic>Tablets - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun, Wei-Jhe</creatorcontrib><creatorcontrib>Aburub, Aktham</creatorcontrib><creatorcontrib>Sun, Changquan Calvin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Wei-Jhe</au><au>Aburub, Aktham</au><au>Sun, Changquan Calvin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J Pharm Sci</addtitle><date>2017-07</date><risdate>2017</risdate><volume>106</volume><issue>7</issue><spage>1772</spage><epage>1777</epage><pages>1772-1777</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><abstract>Maintaining good content uniformity (CU) is a significant challenge for low-dose oral tablets in particular when using direct compression (DC). Using 6 model active pharmaceutical ingredients, we show that a platform DC tablet formulation suitable for developing low-dose API with excellent CU can be developed. This platform formulation is enabled by particle engineering, where an API of interest is loaded in a suitable porous carrier to form a uniform API-carrier composite. Powder properties of such composite particles are dictated by the properties of the carrier, which are insensitive to chemical structure and loading level of the API. Powder flowability, tabletability, tablet friability, and tablet disintegration time are all excellent and only vary within a narrow range among the 6 model APIs. Nearly 100% drug can be released in water from tablets composed of the 6 model APIs. Thus, the approach described here holds the promise for broad application in developing low-dose tablet products using DC possessing excellent CU and other critical quality attributes.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28322940</pmid><doi>10.1016/j.xphs.2017.03.005</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3549 |
ispartof | Journal of pharmaceutical sciences, 2017-07, Vol.106 (7), p.1772-1777 |
issn | 0022-3549 1520-6017 |
language | eng |
recordid | cdi_proquest_miscellaneous_1879666344 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | content uniformity Drug Carriers - chemistry Drug Compounding - methods Excipients - chemistry formulation manufacturability Neusilin particle engineering Pharmaceutical Preparations - administration & dosage Pharmaceutical Preparations - chemistry Porosity Powders Solubility tableting Tablets - chemistry |
title | Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T07%3A09%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Particle%20Engineering%20for%20Enabling%20a%20Formulation%20Platform%20Suitable%20for%20Manufacturing%20Low-Dose%20Tablets%20by%20Direct%20Compression&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Sun,%20Wei-Jhe&rft.date=2017-07&rft.volume=106&rft.issue=7&rft.spage=1772&rft.epage=1777&rft.pages=1772-1777&rft.issn=0022-3549&rft.eissn=1520-6017&rft_id=info:doi/10.1016/j.xphs.2017.03.005&rft_dat=%3Cproquest_cross%3E1879666344%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1879666344&rft_id=info:pmid/28322940&rft_els_id=S0022354917301612&rfr_iscdi=true |